StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Verbindung

Galantamin

HCID 3449
Neue NotizNeue ReaktionAnfrage stellen
Druckvorschau

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
357-70-0
Standard-SMILES
COc1ccc2c3c1OC1CC(O)C=CC31CCN(C)C2
InChIKey
ASUTZQLVASHGKV-UHFFFAOYSA-N
Summenformel
C17H21NO3
Durchschnittliche Molmasse
287,35 g/mol
Monoisotopische Masse
287,15214353

Überblick

LSM-1597 is an alkaloid.

Namen und Bezeichner

Bevorzugter Name
Galantamin
IUPAC
9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol
Englischer Name
Galanthamine
Summenformel
C17H21NO3
Molmasse
287.35

Namen und Synonyme

Galantamin9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol9-methoxy-4-methyl-11-oxa-4-azatetracyclo(8.6.1.01,12.06,17)heptadeca-6(17),7,9,15-tetraen-14-olRefChem:1085649EpigalanthaminMLS000766281NSC1000586H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol,4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aR,6S,8aR)-rel-epigalanthamineGalanthamine #Galanthamine baseGalanthamine,(3.alpha.-
Weitere Namen anzeigen
GALANTAMINEGalantamina(4aS,6R,8aS)-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-olRazadyneGalanthamine-d3 HCl(4aS,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6β-olJilkonReMinylR-113675
Oprea1_097473Oprea1_098077SCHEMBL220427CERAPP_13557CHEMBL1623394SCHEMBL31401865CHEBI:91735DTXSID70859345

Datenbank-Bezeichner

CAS
357-70-0
PubChem CID
3449
DTXSID
DTXSID70859345
ChEMBL
CHEMBL1623394
ChEBI
CHEBI:91735
Nikkaji
J1.441.242E

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
1,8
Polarare Oberfläche (TPSA)
41,9 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
1
Schwere Atome
21
Formalladung
0
Komplexität
440

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals

Physikochemische Eigenschaften

Schmelzpunkt
119 · 119-1210C
Siedepunkt
429.65 °C · 429.65°C (rough estimate)
Dichte
1.0662 · 1.0662 (rough estimate)
Brechungsindex
1.5022 · 1.5022 (estimate)
storage temp.
Sealed in dry,Room Temperature
Löslichkeit
14.37 mg/mL · ≥14.37 mg/mL in DMSO; ≥14.43 mg/mL in H2O with gentle warming; ≥45 mg/mL in EtOH with gentle warming
Aggregatzustand
Powder
pka
8.32 · pKa 8.32 (Uncertain)
Farbe
White to off-white
InChI
InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1
InChIKey
ASUTZQLVASHGKV-JDFRZJQESA-N

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

Sicherheitsdaten

Toxizität
LD50 intraperitoneal in mouse: 10mg/kg
Giftige Stoffe Daten
357-70-0(Hazardous Substances Data)

Chemie und Industrie

Anwendungen · 4 Einträge

BeschreibungGalantamine is an Amaryllidaceae alkaloid which is first obtained from the plant of snowdrop (Galanthus nivalis), and nowadays, it’s extracted from the plants of Narcissus and Galanthus species or obtained from chemosynthesis. In many areas in Europe such as Bulgaria, eastern Turkey, and the Caucasus, the plants of Galanthus are native species. But its earliest pharmaceutical applications are seldom known. Plaitakis and Duvoisin hypothesized that “moly” in ancient Homer’s epic might be snowdrops. In Homer’s epic Odyssey, “moly” was used as an antidote by Odysseus against Circe’s poisonous drugs. To be used as an antidote may be the plants of Galanthus’ oldest medicinal records. But there is not much evidence for that. There is little evidence of the traditional application of the plants of Galanthus, and it is certain that until the Second World War, the plants of Galanthus and other genera of Amaryllidaceae were not frequently used in European drugsItalian scholar Iannello studied Pancratium illyricum L., an Amaryllidaceae species endemic to Sardinia, and isolated a new galantamine-type alkaloid in its leaves. This new galantamine-type compound exhibited a pronounced invitro AChE inhibitory activity (IC50 = 3.5±1.1 μM) in comparison with the reference standard galantamine hydrobromide (IC50=1.5±0.2μM)

OccurrenceGalanthamine is a bulb plant found throughout the world.

HistoryIn the early 1950s, Soviet Union’s scientists started modern medicine research of galantamine. In 1951, the Soviet Union’s pharmacologist Mashkovsky and Kruglikova-Lvova firstly proved its AChE-inhibiting properties, which was published in the paper. In 1957, the Bulgarian pharmacologist Paskov etal. found that the plants of Galanthus were the richest sources of galantamine, which opened a way for its commercial development by the company Sopharma in Bulgaria. Galantamine hydrobromide was launched into market under the trade name Nivalin. Initially, Nivalin was used in anesthesia to antagonize the effects of non-depolarizing muscle relaxants, and since then, it was rapidly introduced in other areas of medicineGalantamine hydrobromide was launched into market for the indication of mild to moderate Alzheimer’s disease firstly in 1995, developed by Sanochemia Pharmaceuticals. In the United States, galantamine hydrobromide was developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, and was listed under the trade name Razadyne in 2001. So far, galantamine hydrobromide has been marketed in more than 20 countries and regions, such as the United States, Europe, and Japan.

Zugehörige Reaktionen

3
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 22461
HRID 22461als Eduktuspto-grants-1995_06
Reaktionsgleichung von HRID 850695
HRID 850695als Eduktuspto-grants-2000_01
Reaktionsgleichung von HRID 850696
HRID 850696als Eduktuspto-grants-2000_01

Notizen zur Verbindung

Wird geladen…

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Weitere Aktionen
Neue NotizNeue ReaktionAnfrage stellen
SMILES
N1(C)CC2=CC=C(OC)C3O[C@]4([H])[C@@](C=C[C@H](O)C4)(C2=3)CC1
CAS Datenbank
357 · 357-70-0(CAS DataBase Reference)
NIST chemische Informationen
Galantamin(357-70-0)

VerwendenA selective acetylcholinesterase inhibitor. Useful for the treatment of Alzheimer's disease.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Ammoniak, wasserfreiNatriumcarbonatSchwefelsureHydrogenbromid

Nachgelagerte Produkte

O-Desmethylgalanthamine(3α)-3-Deoxy-3-chlorogalanthaMine

Ergänzende Hinweise

DefinitionChEBI: A natural product found in Crinum asiaticum var. sinicum.